Similarly, in patients with CNS lymphoma who responded well to chemotherapy, a significant reduction in CSF-CXCL13 was observed compared to in patients with clinical and radiographic progression [19]. The gene discussed is CXCL13; the disease is primary central nervous system lymphoma.